{"product_id":"global-live-cell-imaging-market-size-study-forecast-by-products-services-instruments-consumables-software-services-by-application-cell-biology-stem-cells-developmental-biology-drug-discovery-by-end-user-pharmaceutical-biotechnology-com","title":"Global Live Cell Imaging Market Size study \u0026 Forecast, by Products \u0026 Services (Instruments, Consumables, Software, Services), by Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), by End-User (Pharmaceutical \u0026 Biotechnology Com","description":"\u003cp\u003eGlobal Live Cell Imaging Market Size study \u0026amp; Forecast, by Products \u0026amp; Services (Instruments, Consumables, Software, Services), by Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), by End-User (Pharmaceutical \u0026amp; Biotechnology Companies, Academic \u0026amp; Research Institutes, Contract Research Organizations) and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal Live Cell Imaging Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Live cell imaging can be defined as the study of living cells via analysis systems or high content screening and imaging systems such as cell analyzers, microscopes and many more. These technologies are utilized in number of investigations that offer critical insights into the essential nature of tissue and cellular function. The live cell imaging system has become more popular in the healthcare industry. Rising incidence of cancer, surging adoption of high-content screening techniques in drug discovery, and increasing investments made in research funding are the few factors responsible for high CAGR of the market over the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eFor instance, according to International Agency for Research on Cancer (IARC), approx. 19.3 million new cases of cancer are reported in UN regions in 2020. In the year 2040, it is anticipated that there would be about 28.4 million cases. Thus, the prevalence of cancer is on surging trend across the globe thereby, the need for live cell imaging is expected to increase around the world. Additionally, increasing application of high content screening (HCS) in personalized medicine and growing development of new drugs are the major factors likely to create lucrative growth opportunity to the market in the upcoming years. However, the high cost of high-content screening systems and the shortage of skilled professionals’ stifles market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Live Cell Imaging Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the availability of government funding for life science research, growing advancements in live cell imaging techniques and the rising incidence of cancer in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increase in cancer prevalence, widespread outsourcing activities for research and development and growth in the demand for cancer detection techniques that would create lucrative growth prospects for the Live Cell Imaging market across Asia Pacific region.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nDanaher Corporation\u003cbr\u003e\nCarl Zeiss AG\u003cbr\u003e\nNikon Corporation\u003cbr\u003e\nOlympus Corporation\u003cbr\u003e\nPerkinelmer\u003cbr\u003e\nGE Healthcare\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nSartorius AG\u003cbr\u003e\nCytosmart Technologies\u003cbr\u003e\nBiotek Instruments\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In Sept. 2021, PHC Holdings Corporation's subsidiary PHC Corporation, a market leader in the development, design, and production of lab equipment, recently announced a collaboration with SCREEN Holdings Co. Ltd. The collaboration aims to market live-cell imaging instruments from the SCREEN Cell3iMager line in North America.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Live Cell Imaging Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Products \u0026amp; Services, Application, End-User, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003cbr\u003e\nCustomization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional \u0026amp; segment scope*\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Products \u0026amp; Services:\u003cbr\u003e\nInstruments\u003cbr\u003e\nConsumables\u003cbr\u003e\nSoftware\u003cbr\u003e\nServices\u003cbr\u003e\nBy Application:\u003cbr\u003e\nCell Biology\u003cbr\u003e\nStem Cells\u003cbr\u003e\nDevelopmental Biology\u003cbr\u003e\nDrug Discovery\u003cbr\u003e\nBy End-User:\u003cbr\u003e\nPharmaceutical \u0026amp; Biotechnology Companies\u003cbr\u003e\nAcademic \u0026amp; Research Institutes\u003cbr\u003e\nContract Research Organizations\u003cbr\u003e\nBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRoLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eDanaher Corporation\u003cbr\u003e\nCarl Zeiss AG\u003cbr\u003e\nNikon Corporation\u003cbr\u003e\nOlympus Corporation\u003cbr\u003e\nPerkinelmer\u003cbr\u003e\nGE Healthcare\u003cbr\u003e\nThermo Fisher Scientific\u003cbr\u003e\nSartorius AG\u003cbr\u003e\nCytosmart Technologies\u003cbr\u003e\nBiotek Instruments\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 200 Pages \/ MCW16227733","offer_id":47646782161202,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-live-cell-imaging-market-size-study-forecast-by-products-services-instruments-consumables-software-services-by-application-cell-biology-stem-cells-developmental-biology-drug-discovery-by-end-user-pharmaceutical-biotechnology-com","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}